Riskpilot← Back to searchSign inGet full accessLIFECARE ASA
ASAActiveOrg 990251657Ytrebygdsvegen 215, 5258 BlomsterdalenResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20068 employeeswww.lifecare.no
Revenue 2024
NOK 5,3M
-2% vs 2023
EBITDA margin
-1397.3%
-118% vs 2023
Equity ratio
70.0%
Financial strength
Net profit 2024
NOK -63,7M
-84% vs 2023
| Revenue | NOK 5,3M | -2% |
| EBITDA | NOK -74,5M | -118% |
| Net profit | NOK -63,7M | -84% |
| Total assets | NOK 117,2M | +60% |
| Equity | NOK 82M | +24% |
| Employees | 8 | — |
Legal name
LIFECARE ASA
Org number
990251657
Legal form
Allmennaksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
20. september 2006
Share capital
NOK 29 812 074
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller to styremedlemmer i fellesskap.
Company purpose
Utvikling, produksjon, lisensiering og salg av medisinsk utstyr og teknologi og alt som står i forbindelse med dette.
Address
Ytrebygdsvegen 215, 5258 Blomsterdalen
Website
www.lifecare.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 738 | 3 810 | 1 100 | 676 | 575 | 359 | 1 015 | 1 650 | 1 614 | 551 | 3 486 | 2 069 | 5 391 | 1 275 | 5 482 | 5 431 | 5 332 |
| Staff expenses | −780 | −665 | −0 | −0 | −251 | −251 | −704 | −217 | −198 | −228 | −228 | −342 | −703 | −1 540 | −3 810 | −12 263 | −16 376 |
| EBITDA | −1 380 | −1 255 | −1 832 | −2 154 | −60 | −1 826 | −5 158 | −7 230 | −4 956 | −3 390 | −8 701 | −6 721 | −2 439 | −16 001 | −17 653 | −34 196 | −74 502 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −7 | −7 | −7 | −27 | −27 | −29 | −19 | −19 | −23 | −91 | −561 | −767 |
| EBIT | −1 380 | −1 255 | −1 832 | −2 154 | −60 | −1 833 | −5 165 | −7 237 | −4 982 | −3 417 | −8 730 | −6 740 | −2 458 | −16 024 | −17 744 | −34 757 | −75 269 |
| Net financials | 83 | −39 | 17 | 11 | −7 | 21 | −7 | −257 | −12 | −13 | −63 | 185 | −150 | −46 | 374 | 206 | 11 615 |
| Profit before tax | −1 297 | −1 294 | −1 815 | −2 143 | −67 | −1 812 | −5 172 | −7 494 | −4 994 | −3 431 | −8 793 | −6 555 | −2 608 | −16 070 | −17 370 | −34 551 | −63 654 |
| Tax | −0 | −0 | −820 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −1 297 | −1 294 | −995 | −2 143 | −67 | −1 812 | −5 172 | −7 494 | −4 994 | −3 431 | −8 793 | −6 555 | −2 608 | −16 070 | −17 370 | −34 551 | −63 654 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 119 | 2 253 | 1 324 | 566 | 376 | 1 183 | 2 830 | 2 275 | 1 860 | 1 190 | 23 418 | 17 495 | 14 610 | 29 927 | 64 632 | 73 411 | 117 224 |
| Equity | −5 251 | −6 041 | −985 | −3 128 | −1 423 | 227 | 511 | 1 685 | 848 | −2 351 | 22 239 | 15 733 | 13 326 | 24 046 | 54 936 | 65 903 | 82 015 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 697 | 4 245 | 3 075 | 4 188 |
| Short-term debt | 3 993 | 3 411 | 1 901 | 3 694 | 1 799 | 956 | 2 319 | 590 | 1 012 | 3 541 | 1 179 | 1 762 | 1 283 | 3 183 | 5 451 | 4 433 | 31 021 |
| Total debt | 7 370 | 8 294 | 2 308 | 3 694 | 1 799 | 956 | 2 319 | 590 | 1 012 | 3 541 | 1 179 | 1 762 | 1 283 | 5 880 | 9 696 | 7 508 | 35 209 |
EBITDA margin
-1397.3%
This company
15.8%
Market median
-8944% vs market
20082024
Equity ratio
70.0%
This company
38.2%
Market median
+83% vs market
20082024
Return on equity
-77.6%
This company
18.4%
Market median
-522% vs market
20082024
Net profit margin
-1193.8%
This company
8.1%
Market median
-14838% vs market
20082024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20082024
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JH Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Lacal As | Company | 13.9% | 13.9% | 2024 |
Teigland Eiendom As | Company | 13.3% | 13.3% | 2024 |
Verdipapirfondet Nordea Avkastning | Company | 6.5% | 6.5% | 2023 |
Tjelta As | Company | 5.7% | 5.7% | 2024 |
J.P. Morgan Se | Company | 4.4% | 4.4% | 2024 |
Nordnet Bank Ab | Company | 4.1% | 4.1% | 2024 |
Nordnet Livsforsikring As | Company | 3.1% | 3.1% | 2024 |
| Individual | 2.5% | 2.5% | 2022 | |
F2 Funds As | Company | 2.3% | 2.3% | 2024 |
Spit Air As | Company | 2.2% | 2.2% | 2024 |
| Individual | 2.1% | 2.1% | 2023 | |
| Individual | 1.8% | 1.8% | 2022 | |
| Individual | 1.8% | 1.8% | 2024 | |
| Individual | 1.5% | 1.5% | 2022 | |
Lt Finans As | Company | 1.4% | 1.4% | 2024 |
Hejma As | Company | 1.3% | 1.3% | 2024 |
| Individual | 1.1% | 1.1% | 2022 | |
| Individual | 1.1% | 1.1% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bilforum As
LIFECARE ASA Board members of LIFECARE ASA also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Joacim Holter | Chief Executive Officer | 0 companies |
| Christian Hysing-Dahl | Chairman | 0 companies |
| Tone Kvåle | Board of Directors | 0 companies |
| Renete Kaarvik | Board of Directors | 0 companies |
| Bo Arne Petersson | Board of Directors | 0 companies |
| Kathrine Elisabeth Gamborg Andreassen | Board of Directors | 0 companies |
| Hans Johan Hekland | Board of Directors | 0 companies |
| Tore Birger Ellingsen | Board of Directors | 0 companies |
| Lutz Walter Heinemann | Board of Directors | 0 companies |
| Morten Foros Krohnstad | Chairman | 0 companies |
| Trine Teigland | Board of Directors | 0 companies |